Table. Characteristics of men who have sex with men in retrospective study at sexually transmitted disease outpatient clinic in Amsterdam, the Netherlands*.
| Clinical data | MMA+ |
MMA– |
||||
|---|---|---|---|---|---|---|
| (2002 and 2003) |
(2003) |
|||||
|
C. trachomatis
|
C. trachomatis
|
|||||
| L2b | Non-LGV | Total | L2b | Non-LGV | Total | |
| No. patients | 32 | 12† | 44 | 13 | 17‡ | 30 |
| Anal discharge | 11 | 3 | 14 | 4 | 2 | 6 |
| Genital ulcers | 3 (L2b) | 1 (Treponema pallidum) | 4 | 0 | 1 (HSV-2) | 1 |
| Lymphadenopathy | 4 | 0 | 4 | 2 | 2 | 4 |
| Mean no. infections with sexually transmitted diseases | 8.3 | 5.8 | 7.8 | 7 | 4.6 | 5.8 |
| Known HIV+ | 24 | 6 | 30 | 7 | 7 | 14 |
| >10 leukocytes by Gram stain | 26 | 3 | 39 | 3 | 6 | 9 |
| C. trachomatis lgG ≥200 | 22 | 2 | 24 | 8 | 6 | 14 |
| C. trachomatis lgG <200 | 8§ | 10 | 18 | 4¶ | 11 | 15 |
*MMA, mucous membrane abnormalities; C. trachomatis, Chlamydia trachomatis; LGV, lymphogranuloma venereum; Ig, immunoglobulin. †2 serum samples were not available for testing. ‡1 serum sample was not available for testing. §Serogroup B, n = 5; intermediate serogroup, n = 5; serogroup C, n = 2. ¶Serogroup B, n = 10; intermediate serogroup, n = 1; serogroup C, n = 6.